337 related articles for article (PubMed ID: 15914127)
1. Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding.
Murphy PA; Kern SE; Stanczyk FZ; Westhoff CL
Contraception; 2005 Jun; 71(6):402-8. PubMed ID: 15914127
[TBL] [Abstract][Full Text] [Related]
2. The interaction between St John's wort and an oral contraceptive.
Hall SD; Wang Z; Huang SM; Hamman MA; Vasavada N; Adigun AQ; Hilligoss JK; Miller M; Gorski JC
Clin Pharmacol Ther; 2003 Dec; 74(6):525-35. PubMed ID: 14663455
[TBL] [Abstract][Full Text] [Related]
3. Interaction of St John's wort with low-dose oral contraceptive therapy: a randomized controlled trial.
Pfrunder A; Schiesser M; Gerber S; Haschke M; Bitzer J; Drewe J
Br J Clin Pharmacol; 2003 Dec; 56(6):683-90. PubMed ID: 14616430
[TBL] [Abstract][Full Text] [Related]
4. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy.
Rosenfeld WE; Doose DR; Walker SA; Nayak RK
Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594
[TBL] [Abstract][Full Text] [Related]
5. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
Griffith SG; Dai Y
Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic interactions of drugs with St John's wort.
Zhou S; Chan E; Pan SQ; Huang M; Lee EJ
J Psychopharmacol; 2004 Jun; 18(2):262-76. PubMed ID: 15260917
[TBL] [Abstract][Full Text] [Related]
7. The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).
Markowitz JS; DeVane CL
Psychopharmacol Bull; 2001; 35(1):53-64. PubMed ID: 12397870
[TBL] [Abstract][Full Text] [Related]
8. Co-administration of St. John's wort and hormonal contraceptives: a systematic review.
Berry-Bibee EN; Kim MJ; Tepper NK; Riley HE; Curtis KM
Contraception; 2016 Dec; 94(6):668-677. PubMed ID: 27444983
[TBL] [Abstract][Full Text] [Related]
9. Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol.
Eldon MA; Underwood BA; Randinitis EJ; Sedman AJ
Neurology; 1998 Apr; 50(4):1146-8. PubMed ID: 9566412
[TBL] [Abstract][Full Text] [Related]
10. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C
Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
[TBL] [Abstract][Full Text] [Related]
11. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
12. Does St. John's wort interfere with the antiandrogenic effect of oral contraceptive pills?
Fogle RH; Murphy PA; Westhoff CL; Stanczyk FZ
Contraception; 2006 Sep; 74(3):245-8. PubMed ID: 16904419
[TBL] [Abstract][Full Text] [Related]
13. St John's wort extract (Ze 117) does not alter the pharmacokinetics of a low-dose oral contraceptive.
Will-Shahab L; Bauer S; Kunter U; Roots I; Brattström A
Eur J Clin Pharmacol; 2009 Mar; 65(3):287-94. PubMed ID: 19015839
[TBL] [Abstract][Full Text] [Related]
14. Effect of St John's wort dose and preparations on the pharmacokinetics of digoxin.
Mueller SC; Uehleke B; Woehling H; Petzsch M; Majcher-Peszynska J; Hehl EM; Sievers H; Frank B; Riethling AK; Drewelow B
Clin Pharmacol Ther; 2004 Jun; 75(6):546-57. PubMed ID: 15179409
[TBL] [Abstract][Full Text] [Related]
15. Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone.
Trapnell CB; Donahue SR; Collins JM; Flockhart DA; Thacker D; Abernethy DR
Clin Pharmacol Ther; 1998 Dec; 64(6):597-602. PubMed ID: 9871424
[TBL] [Abstract][Full Text] [Related]
16. Effects of St. John's wort supplementation on ibuprofen pharmacokinetics.
Bell EC; Ravis WR; Lloyd KB; Stokes TJ
Ann Pharmacother; 2007 Feb; 41(2):229-34. PubMed ID: 17284505
[TBL] [Abstract][Full Text] [Related]
17. Thalidomide does not alter estrogen-progesterone hormone single dose pharmacokinetics.
Scheffler MR; Colburn W; Kook KA; Thomas SD
Clin Pharmacol Ther; 1999 May; 65(5):483-90. PubMed ID: 10340913
[TBL] [Abstract][Full Text] [Related]
18. Effect of St John's wort on imatinib mesylate pharmacokinetics.
Frye RF; Fitzgerald SM; Lagattuta TF; Hruska MW; Egorin MJ
Clin Pharmacol Ther; 2004 Oct; 76(4):323-9. PubMed ID: 15470331
[TBL] [Abstract][Full Text] [Related]
19. The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone.
Hendrix CW; Jackson KA; Whitmore E; Guidos A; Kretzer R; Liss CM; Shah LP; Khoo KC; McLane J; Trapnell CB
Clin Pharmacol Ther; 2004 May; 75(5):464-75. PubMed ID: 15116059
[TBL] [Abstract][Full Text] [Related]
20. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
Wang Z; Gorski JC; Hamman MA; Huang SM; Lesko LJ; Hall SD
Clin Pharmacol Ther; 2001 Oct; 70(4):317-26. PubMed ID: 11673747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]